Trials / Conditions / Immune Checkpoint Therapy

Immune Checkpoint Therapy

9 registered clinical trials studyying Immune Checkpoint Therapy — 9 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Node-Sparing Low-Dose Radiotherapy Concurrent With Chemotherapy and PD-1 Inhibitor in pMMR/MSS High-Risk Local NCT07279077	Sixth Affiliated Hospital, Sun Yat-sen University	Phase 2
Recruiting	Node-Sparing Hypofractionated Radiotherapy Plus Chemotherapy and PD-1 Inhibitor in pMMR/MSS High-Risk Locally NCT07230639	Sixth Affiliated Hospital, Sun Yat-sen University	Phase 2
Enrolling By Invitation	Evaluation of Efficacy and Safety of Immune Check Point Inhibitors in Hepatocellular Carcinoma Patients in Ain NCT07088081	Ain Shams University	—
Not Yet Recruiting	Node-Sparing Short-Course Radiotherapy Plus First-Line Therapy and PD-1 Inhibitor in Unresectable/Metastastic NCT06980389	Sixth Affiliated Hospital, Sun Yat-sen University	Phase 2
Recruiting	Node-Sparing Short-Course Radiotherapy Sequential Chemotherapy and PD-1 Inhibitor for Mid/Low pMMR/MSS Rectal NCT06958432	Sixth Affiliated Hospital, Sun Yat-sen University	Phase 2 / Phase 3
Recruiting	Node-Sparing Short-Course Radiotherapy Plus Chemotherapy, Bevacizumab and PD-1 Inhibitor in Metastatic pMMR/MS NCT06958419	Sixth Affiliated Hospital, Sun Yat-sen University	Phase 2 / Phase 3
Recruiting	Modified Long-Course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for MSS/pMMR High-risk Mid/Low L NCT06923345	Sixth Affiliated Hospital, Sun Yat-sen University	Phase 2
Recruiting	A Prospective Real World Evidence Study (PROWES) for Concordance Rate of Blood-based 3D Genome Conformation Ma NCT06635954	Oxford Biodynamics Inc.	—
Recruiting	STRICT - Surveillance With TRoponin During Immune Checkpoint Therapy NCT06337097	M.D. Anderson Cancer Center	N/A